Hyoscine Butylbromide Crescent Pharma (Hyoscine Butylbromide)

The drug acts as a peripheral muscarinic receptor antagonist, blocking M3 receptors on smooth‑muscle cells. This inhibition prevents acetylcholine‑induced contraction, leading to relaxation of the gastrointestinal, biliary and urinary smooth muscle, thereby reducing spasm and associated pain.

The appropriate dose of Hyoscine Butylbromide is determined by the prescribing healthcare professional based on the patient’s condition, age, and response. Dosage may vary between adults and children and should follow the prescriber’s instructions on the product label.

Safety of Hyoscine Butylbromide during pregnancy and lactation has not been fully established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hyoscine Butylbromide is a peripheral anticholinergic that does not cross the blood‑brain barrier, offering targeted smooth‑muscle relaxation with fewer central side effects compared with agents like dicyclomine. It is often preferred for acute colic and cramp relief where rapid onset is desired.

Store the product at ambient temperature, ideally below 25 °C. Keep it in the original packaging to protect from moisture and light. Do not store in a refrigerator or freezer unless otherwise indicated on the label.

Hyoscine Butylbromide is administered orally, typically as a tablet or capsule, and should be taken with water as directed by the prescriber. The dosage form is designed for systemic absorption to act on peripheral muscarinic receptors.

Serious risks include severe allergic reactions, acute glaucoma exacerbation, paralytic ileus, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms such as rash, difficulty breathing, visual disturbances, severe abdominal pain, or irregular heartbeats.

Hyoscine Butylbromide should be avoided in individuals with known hypersensitivity to the drug, severe glaucoma, myasthenia gravis, or significant urinary retention. Caution is also advised for patients with severe renal impairment, and it should be used only under medical supervision in pregnant or breastfeeding women.